1RICHEL D J,VERVENNE W L.Systemic treatment of oesophageal cancer[J].Eur J Gastroenterol Hepatol,2004,16(3):249-254.
2MELUCH A A,GRECO F A,GRAY J R,et al.Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer:final results of a Minnie Pearl Cancer Research Network phase Ⅱ trial[J].Cancer J,2003,9(4):251-260.
3CHOI N,PARK S D,LYNCH T,et al.Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma:mature results of phase Ⅱ study[J].International Journal of Radiation Oncology,Biology,Physics,2004,60(1):111-122.
4URBA S G,ORRINGER M B,IANETTONNI M,et al.Concurrent cisplatin,paclitaxel,and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma[J].Cancer,2003,98(10):2177-2183.
5MURO K,HAMAGUCHI T,OHTSU A,et al.A phase Ⅱ study of single-agent docetaxel in patients with metastatic esophageal cancer[J].Ann Oncol,2004,15(6):955-959.
6PASINI F,de MANZONI G,PEDRAZZANI C,et al.High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy:dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin,docetaxel and concurrent radiotherapy[J].Ann Oncol,2005,16(7):1133-1139.
7CONROY T,ETIENNE P L,ADENIS A,et al.Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus:response,toxicity,quality of life and survival[J].Ann Oncol,2002,13(5):721-729.
9KODAIRA T,FUWA N,KAMATA M,et al.Single-institute phase Ⅰ/Ⅱ trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma[J].Anticancer Research,2006,26(1B):471-478.
10JINGU K,NEMOTO K,MATSUSHITA H,et al.Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer[J].BMC Cancer,2006,6:50.
二级参考文献10
1[1]Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma:a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer [J]. World J Surg, 1992, 16(6): 1104- 1110.
2[2]Wang M, Gu XZ, Yin WB, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients [J].Int J Radiat Oncol Biol Phys, 1989, 16 (2): 325 -327.
3[3]Gignoux M, Roussel A, Paillot B, et al. The value of preoperative radiotherapy in esophageal cancer: results of a study by the EORTC [J]. Recent Results Cancer Res, 1988, 110:1 -13.
4[4]Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus [J]. N Engl J Med, 1997, 17, 337(3):161 - 167.
5[5]Le Prise E, Etienne P L, Meunier B, et al. A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the esophagus [J]. Cancer,1994, 73:1779 - 1784.
6[6]Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer [J]. Hepatogastroenterology, 1994, 41(4): 391-393.
7[7]Hennequin C, Gayet B, Sauvanet A, et al. Impact on survival of surgery after concomitant chemoradiation for locallyadvanced cancers of the esophagus [J]. Int J Radiat Oncol Biol Phys,2001, 49:657-664.
8[8]Slater MS, Holland J, Faigel DO, et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma? [J]. Am J Surg, 2001, 181: 440-444.
9[9]Noguchi T, Moriyama H, Wada S, et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma [J]. Dis Esophagus, 2003, 16(2): 94-98.
10[10]Lee JL, Kim SB, Jung HY, et al. Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma-a single institutional study [J]. Acta Oncol, 2003, 42(3): 207-217.
